Individual Baselines Inc is categorized under Specialty Outpatient Clinics, Nec in Albuquerque, NM and active since 2007.
Individual Baselines Inc was established in 2007, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Specialty Outpatient Clinics, Nec business, which does work in the B2C market, and is classified as a Specialty Outpatient Clinics, Nec, under code number 621498 by the NAICS.
If you are seeking more information, feel free to contact Diego Guillen at the company’s single location by writing to 4223 Montgomery Boulevard Ne, Albuquerque, New Mexico NM 87109 or by phoning (913) 890-7269. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Individual Baselines Inc |
Contact Person: | Diego Guillen |
Address: | 4223 Montgomery Boulevard Ne, Albuquerque, New Mexico 87109 |
Phone Number: | (913) 890-7269 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2007 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Specialty Outpatient Clinics, Nec |
SIC Code: | 8093 |
NAICS Code: | 621498 |
Share This Business: |
Individual Baselines Inc was started in 2007 to provide professional Specialty Outpatient Clinics, Nec under the SIC code 8093 and NAICS code 621498. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Diego Guillen for inquiries that concern Individual Baselines Inc by calling the company number (913) 890-7269, as your correspondence is most welcome. Additionally, the physical location of the single location of Individual Baselines Inc can be found at the coordinates as well as the street address 4223 Montgomery Boulevard Ne in Albuquerque, New Mexico 87109.
For its online presence, you may visit Individual Baselines Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.